Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
about
Phenotypic Heterogeneity of Monogenic Frontotemporal DementiaNew developments and future opportunities in biomarkers for amyotrophic lateral sclerosisBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?Body fluid biomarkers in Alzheimer's diseaseThe use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and researchThe Mental Status Examination in Patients With Suspected Dementia.Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient AutopsiesUse of biomarkers in ALS drug development and clinical trialsDiscriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.Motor neuron disease in 2014. Biomarkers for ALS--in search of the Promised LandBack to the tubule: microtubule dynamics in Parkinson's disease.Biomarkers in the primary progressive aphasiasDrugs in clinical development for the treatment of amyotrophic lateral sclerosis.Further development of biomarkers in amyotrophic lateral sclerosis.Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression.Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition.Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementiaDiagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study
P2860
Q26782984-6FE3FF0E-F43B-4ACC-BBD1-F2D69C0A9E9FQ26783410-44555F13-1FE6-45AD-AAAC-BC93C4FD32BBQ26799233-F0D221F2-455F-4D35-885B-BBF4621C24DBQ26830098-C3F182C8-42DB-4A07-BFD1-8A26040F653FQ28088291-6835BC5F-3B7F-477D-823B-DD7663A19BC1Q33562433-85BA9614-0403-472A-A7B0-891595006F87Q35204586-AE42B00B-DAFA-4FD1-A974-D076C81224F7Q36030708-40FA0535-6C4D-4984-8FDA-E83B2AC16495Q36733981-0D660833-39FB-44EB-A8C5-875939CD1E92Q36933708-2A81F233-650D-4F0C-9457-2549363D8721Q37532592-635BB143-235E-409D-ABBA-F2428E75A12CQ37590635-0A476C42-F7AC-47CB-B201-8683FFB17343Q38314824-AC245A57-8753-4E1B-A9C7-D1AA6D419FF2Q38748144-C471A4D5-D753-4016-9D32-76613A920E9AQ38856405-BF5E93D6-6168-44F8-B7D3-BB607B55D986Q40118660-D304F500-B43D-44EA-8108-DC72506B621AQ40385384-7CC54338-415D-4DE5-B8F7-612599457C40Q45870549-C2EF8F7A-1C02-4A0C-A8BA-D62674CC153CQ47819962-3886C8C6-F069-41CB-AFA1-908F91F951F6Q47860695-3ACF8102-821F-413B-9A9E-C3CD75206A37Q50706880-0189DE0E-8613-4FA0-9F03-9F0E534274ABQ53396239-1A79B2E1-7AE9-48EA-80F2-F940D8C9E77AQ53396502-BC705E7E-D0FA-4E8A-8197-B85867AD1A1BQ58280051-5E6F6D30-8414-4E34-9D3C-9F1A2CFF137BQ58698208-C38AC9E4-15A0-4BD2-8D5D-DEA4FE08F8C0
P2860
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@en
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@nl
type
label
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@en
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@nl
prefLabel
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@en
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
@nl
P2093
P2860
P50
P921
P1433
P1476
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis
@en
P2093
Ashley Boller
David J Irwin
John Q Trojanowski
Katya Rascovsky
Lauren Elman
Leo McCluskey
Murray Grossman
Virginia M-Y Lee
P2860
P304
P356
10.1001/JAMANEUROL.2013.6064
P407
P577
2014-04-01T00:00:00Z